Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC

Name: Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC
License: Public Domain

Swiss Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

nsclc, nsclc (advanced non-small cell lung cancer)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 314317
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.